Next Article in Journal
The Venom Proteome and Immunorecognition Profile of Clinically Important Echis carinatus sochureki from Northwestern India Underscores the Need for Regionally Specific Antivenoms
Previous Article in Journal
Reply to Peigneur et al. The Helix Ring Peptide U11 from the Venom of the Ant, Tetramorium bicarinatum, Acts as a Putative Pore-Forming Toxin, Not a New Kv1.3 Channel Blocker. Comment on “Boy et al. A New Kv1.3 Channel Blocker from the Venom of the Ant Tetramorium bicarinatum. Toxins 2025, 17, 379”
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

High-Resolution LC–MS Characterization of Ramaria flavobrunnescens, a Coral Mushroom Toxic to Livestock, Reveals Fungal, Bacterial, and Eucalyptus Tree Metabolites

1
London Research and Development Centre, Agriculture and Agri-Food Canada, 1391 Sandford Street, London, ON N5V 4T3, Canada
2
Pacific Forestry Centre, Canadian Forest Service, Natural Resources Canada, 506 Burnside Rd W, Victoria, BC V8Z 1M5, Canada
3
Plataforma de Investigación en Salud Animal (PSA), Instituto Nacional de Investigación Agropecuaria (INIA), Estación Experimental Tacuarembó, Tacuarembó 45000, Uruguay
*
Author to whom correspondence should be addressed.
Toxins 2026, 18(1), 53; https://doi.org/10.3390/toxins18010053
Submission received: 19 December 2025 / Revised: 6 January 2026 / Accepted: 16 January 2026 / Published: 20 January 2026
(This article belongs to the Section Mycotoxins)

Abstract

Ramaria flavobrunnescens is an ectomycorrhizal coral mushroom that is often found growing in eucalyptus forests. The mushroom has been linked to accidental ingestion-associated livestock poisonings in South America, though the toxicological agent has not yet been described. Mushroom samples identified as R. flavobrunnescens were analyzed by liquid chromatography high-resolution mass spectrometry (LC–MS/MS) to determine the potential source of the toxicity, and to provide a metabolomic profile of the species. Previously reported Ramaria secondary metabolites were detected, including ramarins, ramariolides, pistillarin and arsenic-containing compounds. A number of bacterial species were isolated from R. flavobrunnescens that produced iron-chelating cyclic peptides, which were detected in the mushroom samples. Interestingly, we detected a series of eucalyptus tree secondary metabolites in abundance from R. flavobrunnescens fruiting bodies, some of which have reported toxicities and bioactivities. To our knowledge, this is the first report of eucalyptus secondary metabolites in a mushroom. The diversity of secondary metabolites identified in the mushroom extracts provides insight into the potential complex ecological interactions between R. flavobrunnescens, its associated microbiota, and its mycorrhizal interaction with eucalyptus trees.
Key Contribution: The causative agent of mushroom-associated livestock poisoning was investigated using liquid chromatography high-resolution mass spectrometry. LC–MS profiling of Ramaria flavobrunnescens identified previous reported Ramaria metabolites and arsenic compounds, and a number of formylated phloroglucinol compounds from eucalyptus trees.

1. Introduction

Mushrooms host a broad array of diverse biochemical capabilities due, in part, to occupying distinct niches globally, making them a rich source of bioactive natural products. While approximately 2000 mushroom species are classified as edible, it is estimated that approximately 643 mushroom species are known to be poisonous or capable of producing toxins [1,2]. The most commonly encountered mushroom toxicity comes from amatoxins, which are cyclic peptides predominantly produced across three genera: Amanita, Lepiota, and Galerina [3]. Beyond direct toxicity, mushrooms also play multifaceted ecological roles, with some ectomycorrhizal fungi characterized as facultative saprotrophs, and also harboring diverse fungal and bacterial communities associated with their mycelial mats and fruiting bodies [4,5].
Ramaria flavobrunnescens (also referred to as R. flavo-brunnescens) is a coral mushroom (Figure 1), named for its coral-like, dichotomously branching sexual fruiting bodies (basidiomata), and it belongs to the family Gomphaceae. The species apparently forms an ectomycorrhizal relationship with conifers and eucalyptus trees, and has a widespread distribution throughout Uruguay, Brazil, Argentina, Australia, and the southern United States. It is reported as the causative agent of accidental mushroom poisoning in eucalyptus forest-grazing livestock in temperate areas of South America, where it causes substantial economic impacts to farmers. Numerous spontaneous outbreaks have been recorded since the late 1950s in Uruguay, Argentina, and Southern Brazil, where silvopastoral agricultural systems are common practice, with outbreaks in some years resulting in over 96% herd fatality [6,7]. After ingestion, livestock experience acute gastrointestinal and neurological symptoms, including a characteristic loss of hair from the tail; loosening of the horn and hoof; ulcerative and gangrenous lesions on the skin, tongue, and esophagus; lameness; anorexia; and death in severe cases [8]. The causative agent(s) responsible for this toxicity has not been determined, likely due to the instability of the suspected toxins in the mushrooms after harvest. Previous studies that attempted to characterize the toxicological agents determined that the mushroom loses toxicity after being harvested or frozen, and is completely nontoxic after cooking or desiccation [9,10]. Due to the suspected instability of the compounds, it is believed that the causative agent is a thermolabile volatile alkaloid.
The symptoms and pathogenesis in cattle after controlled ingestion of fresh material were summarized in a review by Scheid et al. (2022) [8]. Symptoms appeared anywhere between three to eight days after ingestion, and pathology was suspected to be correlated to exposure to either trichothecenes, ergoalkaloids, or an unknown agent involved in the disruption of sulfur metabolism [11,12,13]. Chemical analysis is further complicated by the apparent obligate ectomycorrhizal dependence of R. flavobrunnescens on eucalyptus. We are unable to find reports of a method to isolate this fungus in pure culture. There are also abiotic factors that could potentially influence the toxicity [6]. Other Ramaria species have been classified as mildly poisonous and have been implicated in accidental poisonings. For example, if ingested in the fall months, R. formosa causes gastrointestinal issues due to an uncharacterized toxicological agent [14].
Modern analytical applications such as liquid chromatography tandem mass spectrometry (LC–MS/MS) can be used for both targeted and untargeted profiling, to either screen for known toxin classes, or for compound discovery. The best characterized species of Ramaria using LC–MS are the edible species, including R. botrytis and R. flava [15]. Therefore, the bulk of the Ramaria metabolomic profiling has centered around their nutritional composition, trace element accumulation, and their role in traditional medicine through profiling of the bioactive metabolites from the edible species. Several bioactive compounds, including fatty acids, phenolics, carotenoids, and antioxidants, have been previously characterized from edible Ramaria species by LC–MS [15,16,17]. Arsenic speciation was conducted on several species of Ramaria (R. subbotrytis, R. largentii, and R. pallida) using inductively coupled plasma mass spectrometry (ICP-MS) [18]. Other known Ramaria secondary metabolites include the ramarin sesquiterpenes from R. formosa, and ramariolides A–D from R. cystidiophora [19,20].
Despite the nutritional significance of some species of Ramaria, a more systematic examination of secondary metabolite production, especially for R. flavobrunnescens, has not been reported. In this study, we report the analysis of fruiting bodies of R. flavobrunnescens that were implicated in cattle toxicosis from Uruguay using high-resolution LC–MS to determine its secondary metabolite profile, and to determine any potentially toxic compounds or compound classes. The mushroom-associated bacteria and fungi were studied to assess their approximate contributions to the toxicity observed in outbreaks.

2. Results and Discussion

2.1. Determination of Secondary Metabolites from R. flavobrunnescens Extracts

From the initial mushroom pieces from Tacuarembó, Uruguay, material extracted with 79:20:1 acetonitrile: water: acetic acid resulted in the highest diversity of secondary metabolites (Supplementary Table S4). However, ethyl acetate was the best extraction method for nonpolar Ramaria secondary metabolites. Extraction of the lyophilized material yielded the highest number of detected peaks overall (n = 4884), compared to analysis of fresh weight material (n = 1539) (Supplementary Table S6). Unfortunately, many of the putatively identified compounds in the extracts could not be fully elucidated or quantified due to the lack of commercial standards available.

2.1.1. Known Ramaria Secondary Metabolites

Extracts were first qualitatively investigated for any known secondary metabolites from the Ramaria genus. R. flavobrunnescens produced several compounds in the fresh weight ethyl acetate extracts that were previously reported from other Ramaria species, including the aristolane sesquiterpenes ramarin A/nambinone A (not distinguishable by MS/MS), ramarin B, axinysone A, and ramariolides (Figure 2). Of these, ramariolides A–D were detected in the highest abundances by peak area, with ramariolide A/B being the most abundant (Supplementary Figure S1). The ramarins were detected in low to modest amounts by peak area in the extracts. Kim et al. (2015) previously characterized the ramarin sesquiterpenes from the edible coral mushroom R. formosa, and reported minor inhibitory activity towards human neutrophil elastase [19]. Nambinones have also been described in Neonothopanus nambi (a bioluminescent mushroom), and were shown to have in vitro cytotoxicity towards a number of cancer cell lines [21]. Though their mammalian toxicity remains unclear, other aristolane-type sesquiterpenes and sesquiterpene lactones have reported cytotoxicity towards P-388 mouse leukemia cells, antimicrobial activity against Staphylococcus aureus, and can inhibit melanin synthesis [22,23,24]. The butanolide ramariolides, which were previously described in R. cystidiophora, showed antimycobacterial activity against Mycobacterium smegmatis and M. tuberculosis in cytotoxicity assays [20].

2.1.2. Arsenic-Containing Compounds

Beyond the known secondary metabolites reported from Ramaria, the search was also expanded to include compounds reported across other mushroom genera. Several early-eluting compounds (~0.6 min) were observed in moderate abundance by peak area from samples extracted using the alkaloid extraction method—these were later identified as arsenic-containing compounds. Arsenobetaine (AB) (Figure 3) was identified as the major nontoxic arsenic-containing compound in R. flavobrunnescens based on published MS/MS fragmentation data [25,26]. We also putatively identified tetramethylarsonium (TETRA), dimethylarsinoylacetate (DMAA), and trace amounts of homoarsenocholine (AC2).
Arsenobetaine (AB) is known to be the major organic arsenical compound in most mushrooms, including other species of Ramaria [18,27,28]. Arsenobetaine has been hypothesized to act as an osmolyte to maintain structure of fruiting bodies, which potentially accumulates AB or arsenic-containing compounds from the environment [29]. Organic arsenic compounds are much less toxic than their inorganic forms, arsenate [As(V)] and arsenite [As(III)]. Arsenate has been shown to compete for phosphates, and can inhibit ATP production in cells [30]. Arsenite can reversibly bind the thiol moieties of reduced cysteine residues of enzymes [31]. It has been suggested that the microbial community and substrate may influence arsenic-speciation in mushrooms [29]. Some mushrooms, such as the mycorrhizal Sarcosphaera coronaria and Cyanoboletus pulverulentus, can accumulate arsenic in their fruiting bodies as methylarsonic acid (MA) or dimethylarsonic acid (DMA) [32]. Interestingly, S. coronaria also has an unknown toxicological origin with sporadic toxicity. While inorganic arsenic remains acutely more toxic than organic arsenic or arsenicals, the presence of iron-chelating siderophores may increase the bioavailability of inorganic arsenic [33,34]. Arsenic-containing compounds have been shown to change their speciation after cooking or after ingestion [35,36,37]. Though arsenic poisoning may potentially mimic a few of the symptoms, it is unlikely to be the causative agent of R. flavobrunnescens-associated poisoning.

2.1.3. Iron-Chelating Siderophores and Cyclic Nonapeptides

Beyond known mushroom toxins and secondary metabolites, all extracts were investigated for a broad range of microbial natural products. The known iron-chelating siderophore pistillarin (Figure 4) was detected in minor amounts from the 79:20:1 acetonitrile: water: acetic acid mushroom extracts using the GNPS MS/MS library search database for compound dereplication.
Pistillarin has previously been described from Ramaria botrytis [38]. Both pistillarin and pistillarin B (not detected in R. flavobrunnescens in this study) showed antilipid peroxidation activity [38]. Mushrooms have previously been reported to have antilipid peroxidation activity if they are grown in particularly UV-exposed or polluted areas [39]. Sakemi et al. (2022) suggested that Ramaria species, which can have ectomycorrhizal relationships with plants, may have a role in plant protection by secreting pistillarin when plants are under oxidative stress [38]. It is thought to inhibit lipid peroxidation by chelating iron or other metals involved in peroxidation. Pistillarin has also been reported from filamentous fungi, such as Penicillium bilaiae, though its role is predominantly iron acquisition in iron-depleted environments [40].
Interestingly, freeze-dried mushroom extracts also revealed large peptide-containing clusters between 1100 and 1200 Da, which also were shown to have iron adducts in their mass spectra (Δ 53.9396 Da). Peptide sequencing using MS/MS revealed that these compounds belonged to the WLIP/viscosin/massetolide family of cyclic nonapeptides (Figure 5) [41]. They exist in both cyclic and straight-chain forms and contain a characteristic β-decanoyl group bound to an N-terminal leucine residue. It is unclear which class the compounds belong to as their differentiation is either a leucine/isoleucine, or different L/D confirmation, which cannot be differentiated without derivatization.
The WLIP/massetolide/viscosin compounds have not previously been reported from mushrooms. They are commonly associated with Pseudomonas species in the fluorescens species complex, which have been detected in a wide range of environmental substrates, including mushrooms [42]. The compounds are all bioactive, though their biological activities differ. All three compounds have similar modular nonribosomal peptide synthase (NRPS) biosynthetic gene clusters [43]. WLIP (White Line Inducing Principle) is antifungal, inhibits the growth of Gram-positive bacteria, and has been shown to affect membrane permeability [41,44]. Massetolides and viscosin have been shown to be active against mycobacteria and have roles in biofilm formation and rapid host colonization [43,45,46]. Viscosin-producing P. fluorescens was shown to influence soil microbiota in wheat cultivars, suggesting a possible plant–bacteria relationship. Cucumber plants have been shown to absorb and mobilize iron through their roots when iron-chelated siderophores were supplied hydroponically [47]. Iron cycling has been shown to have a crucial role in white rot fungi in order to degrade the lignin and cellulose in woody substrates via the Fenton reaction [48,49]. This suggests a potential means of ectomycorrhizal iron cycling between the tree and the mushroom, or between the mushroom and the bacteria.
Due to the overall relative abundance in the samples (by peak area) and potential microbial origins of the identified WLIP/massetolide/viscosin compounds, mushroom pieces were surface-sterilized and plated to determine the potential source. Two bacterial species were isolated from surface-sterilized mushroom segments. The 16S bacterial sequencing confirmed that they were Pseudomonas fluorescens and the known mushroom pathogen Ewingella americana. The liquid culture extracts from P. fluorescens and E. americana isolates were then analyzed by LC–MS/MS analysis to determine whether any abundant compounds were also detected in the R. flavobrunnescens extracts.
Ewingella americana is a rare Gram-negative bacteria from the Enterobacteriaceae family that was described in 1983 [50]. It is a known mycopathogen of the edible mushrooms Agaricus bisporus, Lentinula edodes, Pleurotus ostreatus, and Flammulina velutipes, causing internal stipe necrosis and brown blotch disease [51,52,53]. The species has a global distribution and wide host range, also isolated from decomposing fungal biomass, soil, mollusks, nutria, vacuum packaged beef, and humans [54,55,56,57,58,59]. The species expresses chitinases, has demonstrated phenol biodegradation capability, and is resistant to several antibiotics [54,60,61].
Under the conditions tested, the Ewingella americana extract did not contain compounds that were also detected in the mushroom fruiting bodies. However, the P. fluorescens extract was shown to produce the cyclized version of the WLIP/massetolide/viscosin family, as well as the iron adduct versions, indicating that these compounds were not biosynthesized by the fungus.
A number of microbial endophytes and saprotrophs have been characterized in edible mushrooms and are predominantly reported as Pseudomonas species. Some saprophytic bacterial species from the Pseudomonas reactans species group have been isolated from the cultivated mushroom Agaricus bisporus (white button mushroom) and shown to produce WLIP lipodepsipeptides [62]. Berendsen et al. (2012) screened 160 strains of Pseudomonas species isolated from mushrooms, and determined that the mushroom pathogen Lecanicillium fungicola (causal agent of dry bubble disease) was extremely sensitive to siderophore production and competition for iron [63]. The production of WLIP has been detected in the Pseudomonas reactans species group, though cultured strains appear to lose virulence and the ability to produce WLIP [64]. This suggests that WLIP is a potential virulence factor and that its production is linked to the mushroom–bacterial interaction.

2.1.4. Formylated Phloroglucinol Compounds (FPCs) from Eucalyptus

After identifying known secondary metabolites from fungal and bacterial origin, the mushroom extracts were qualitatively analyzed using nontargeted analysis (NTA). Two major unknown compounds (C28H40O6 and C28H38O7) were initially detected in high abundance (by peak area) from ethyl acetate extracts of R. flavobrunnescens in negative ionization mode (Figure 6A). Using the GNPS dereplicator module, these compounds were putatively identified to be eucalyptin A and eucalyptone, which are a class of formylated phloroglucinols (FPCs) known from eucalyptus trees. FPCs are a structurally diverse class of bioactive secondary metabolites produced by members of the large eucalyptus family [65,66]. Based on published MS/MS transitions of known FPCs, the two abundant compounds by peak area were putatively confirmed to be in the same compound class but could not be elucidated to an individual compound due to the diversity of isobaric FPCs. For additional confirmation, mushroom extracts were then compared to extracted raw eucalyptus leaves and extracted eucalyptus essential oil (Figure 6A,B). Detected compounds were compared to commercially available analytical standards to determine the most abundant FPC compounds in the Ramaria extracts. A C8 column was used for better resolution of structurally related FPCs.
Macrocarpals A, C, and N were the only FPC compounds that could be positively identified in the R. flavobrunnescens extracts based on both the availability and quality of commercial standards (Supplementary Figures S3–S5, Supplementary Table S3). Euglobals Ia1 and Ia2 had similar retention times to the putatively identified euglobals in the mushroom extracts, but had differing fragmentation patterns; thus, different unidentified euglobals are likely present (Supplementary Figure S3). Macrocarpals D and E were not detected in the Ramaria ethyl acetate extracts (Supplementary Figure S5). Macrocarpal A is a major FPC in eucalyptus leaves and was also found in the highest concentration in the R. flavobrunnescens sample (60.7 µg/kg) [65,66,67,68]. Lower amounts of macrocarpal C (21.3 µg/kg) and N (24.5 µg/kg) were determined in the same sample.
Eucalyptone and macrocarpal N (Figure 7) are sesquiterpene macrocarpals with reported antibacterial activity [69,70]. Other macrocarpals (including eucalyptone) have been shown to inhibit glucosyltransferase activity, which is linked to biofilm formation or peptidoglycan synthesis in microbes [71,72,73,74]. Sideroxylonals from eucalyptus species are the primary antiherbivory compounds involved in directly affecting foraging behaviour through their bitter taste [75]. Eucalyptus extracts have antimicrobial, antiviral, and antiinsectan activity [76,77,78,79,80,81]. Eucalyptus essential oils and extracts have reported toxicity in humans in high doses [82,83,84]. This is predominantly attributed to 1,8-cineole (eucalyptol) and cyanogenic glucosides. Symptoms of eucalyptus poisoning includes GI issues (abdominal pain, vomiting) as well as central nervous system effects (disorientation, drowsiness, poor muscle control, and tremors), convulsions, hypoventilation, rapid heart rate, drooling or frothing, and issues with temperature regulation (resulting in hypothermia or hyperthermia) [85,86,87,88]. Eucalyptol is a volatile terpene, and is susceptible to light and temperature degradation [89]. Neither eucalyptol nor cyanogenic glucosides could be detected in the initial extracts, but the high relative abundance of other eucalyptus compounds may imply their presence and warrants more targeted analysis of fresh material to confirm.
Due to the peak area abundance of the FPCs in the R. flavobrunnescens extract, it was suspected that more related compounds were present. To determine whether any additional structurally related FPC compounds were in the R. flavobrunnescens extracts, the known diagnostic product ions for the structurally conserved regions of macrocarpals (m/z 207.0274) and sideroxylonals (m/z 249.0747, 181.0119) were used for product ion filtering (Supplementary Figure S1) to find additional related compounds [65]. Using product ion filtering, 40 potentially distinct structurally related compounds were identified with shared fragmentation pathways for macrocarpals and sideroxylonals. Compounds were shown to primarily elute between 4 and 6 min, with most formulae representing between 3 and 5 different isobaric peaks (Supplementary Table S2). Of the 40 molecular formulae, 27 were unable to be putatively identified from known FPCs. Some 38 molecular formulae were found in eucalyptus leaf extracts, and 19 were found in the eucalyptus oil extract. Eight molecular formulae were solely found in the ethyl acetate mushroom extract.
Profiling of known FPCs by LC–MS has been previously accomplished by Okba et al. (2017, 2021) and Dos Santos et al. (2019) in leaves, flowers, and flower buds across several eucalyptus species [65,68,90]. Due to the nonpolar nature and structural diversity of the FPCs, it is an analytical challenge to fully elucidate and quantify all related compounds. Semi-quantification of structurally related isobaric compounds using a surrogate standard has been used previously in other plant matrices. Similarly, Roridin A was used for the estimation of total macrocyclic trichothecenes in Baccharis coridifolia as ‘roridin A equivalents’ [91]. Dos Santos et al. (2019) used commercial standards of macrocarpal A and sideroxylonal A for the estimation of total macrocarpals and sideroxylonals, respectively, in eucalyptus matrices [65]. Following previous works on semi-quantification using surrogate compounds by Santos et al. (2019) [65] and Machado et al. (2023) [91], the quantities of the other major FPCs in the Ramaria extracts are instead estimated here as “macrocarpal A equivalents”. For the 40 related FPCs detected by product ion filtering, it can be estimated that the original R. flavobrunnescens extract had a total of 5.36 µg/g macrocarpal A equivalents. The molecular formulae with the highest concentrations were C26H28O10 (m/z 499.1609 [M-H]; 3.17 µg/g), C28H40O6 (m/z 471.2736 [M-H]; 0.483 µg/g), C28H38O5 (m/z 453.2633 [M-H]; 0.389 µg/g), C28H38O7 (m/z 485.2535 [M-H]; 0.358 µg/g), and C33H36O11 (m/z 635.2842 [M-H]; 0.186 µg/g).
This may represent one of the first reports of plant-derived compounds bioaccumulating in mushroom fruiting bodies. While eucalyptus compounds have not yet been reported to bioaccumulate in mushrooms, other edible mushroom species, including Pleurotus ostreatus and Favolus tenuiculus, have been reported to biotransform 1,8-cineole (eucalyptol) from eucalyptus waste into two new related oxygenated derivative compounds [92]. Monoterpenes and sesquiterpenes are naturally abundant in soil, woody material, and decomposing leaf material, with some studies supporting that terpenes affect soil nutrient cycling and decomposition. This suggests the possibility that R. flavobrunnescens and other ectomycorrhizal mushrooms may have the potential to adapt to potentially toxic variants of terpenes (such as eucalyptol) [93,94]. While some plant-associated fungi can detoxify host defense compounds [95,96,97], bioaccumulating them in fruiting bodies may indicate a broader capacity to sequester, transform, or tolerate specialized plant metabolites, with the additional advantage of providing antifeedant properties that may reduce grazing pressure on fruiting bodies.
Alternatively, some endophytic fungi can produce the same or analogous biologically active secondary metabolites as their plant hosts, including those with antifungal properties, such as camptothecin [98,99,100]. This may be driven by horizontal gene transfer or convergent evolution of biosynthetic gene clusters. Kusari et al. (2011) hypothesized that fungal endophytes intrinsically possess resistance to antagonistic host secondary metabolites, such as camptothecin, and may later acquire additional co-evolutionary resistance traits through prolonged host–endophyte interaction [101]. The fungus Inonotus obliquus, known as the chaga mushroom and widely used for therapeutic and medicinal purposes, is a pathogen of birch (Betula) trees. Both I. obliquus and its host tree produce the triterpenoids betulin and betulinic acid, with evidence suggesting that betulin biosynthesis evolved independently in the fungus through long-term co-evolution with its host [102]. Another decay fungus, Fulvifomes xylocarpicola, produces fruiting bodies that contain the same limonoid triterpenoids as its host, although the origin of these secondary metabolites remains unknown [103]. Ecologically, plant–fungus associations may influence the secondary metabolite profiles of fungal fruiting bodies, with implications for fungal fitness and interactions with other organisms. Future elucidation of the origin of FPCs in the Ramaria mushrooms may include comparative genomic approaches to identify putative terpene, polyketide, or hybrid biosynthetic gene clusters, complemented by transcriptomic analyses to assess the expression of fungal terpene synthases from mushrooms. In addition, stable-isotope labeling could determine whether the metabolites incorporate fungal-derived carbon (supporting endogenous biosynthesis) or host-derived carbon (indicating uptake or transformation of plant compounds).
The estimation of total macrocarpal A equivalents is likely a low-end approximation of the actual FPCs present in fresh fruiting body material, as their fate and persistence in the plant–mushroom–microbiota niche is unknown. It is also unknown whether FPCs can be further biotransformed by associated microorganisms occupying the same niche. The estimated amount is also unlikely to be solely responsible for the extent of livestock poisoning reported in South American pastures. The suspect toxin(s) is known to be unstable from previous analyses, so the active agent(s) may not have been present in the original sample materials at the time of analysis. Although the mushroom was sampled from a pasture with previous livestock poisonings, it was unclear if this mushroom specimen was directly associated with any toxicological effects. Future studies will need to ensure additional sampling considerations to better preserve the volatiles and potentially unstable compounds.

3. Conclusions

Both targeted and nontargeted analysis using high-resolution LC–MS/MS were used for a comprehensive secondary metabolite profile from R. flavobrunnescens. Known Ramaria compounds were identified, including arsenic-containing compounds, and previously described sesquiterpenes. Iron-chelating nonapeptides were observed in mushroom fruiting body extracts and were determined to originate from bacterial isolates from R. flavobrunnescens material. Nontargeted analysis of the fruiting body material determined that the most abundant compounds were FPCs from eucalyptus. The unexpected relative abundance from both plant and microbial sources warrants further study into the dynamic plant–mushroom–microbial communities in eucalyptus understories. This will include comparative whole-genome sequencing for mining of candidate toxigenic clusters, and determination of the potential biosynthetic rationale behind FPC bioaccumulation in R. flavobrunnescens fruiting bodies. Despite the integrative analysis into R. flavobrunnescens, the toxic agent responsible for cattle deaths still cannot be unequivocally determined and warrants further analysis of toxicosis-linked material.

4. Materials and Methods

4.1. Ramaria flavobrunnescens Identification and Sample Collection

Twenty mushroom samples were collected from the base of Eucalyptus camaldulensis trees by the Department of Tacuarembó during May 2024 (autumn in the Southern Hemisphere) on a farm in Uruguay with a previous history of Ramaria flavobrunnescens poisoning in cattle. The samples were labeled 1–20 and stored at −80 °C. For shipment, they were kept on dry ice, and mushroom pieces were placed into 1.7 mL microcentrifuge tubes for LC–MS analysis.

4.2. Chemicals and Analytical Standards

Optima LC–MS-grade water, acetonitrile, methanol, and formic acid (Fisher Scientific, Hampton, NH, USA) were used for sample reconstitution, mobile phase, and buffer preparation. Ethyl acetate, hexane (ACS grade), acetic acid (ACS Plus), and ammonium bicarbonate were purchased from Fisher Scientific. Analytical standards of macrocarpals A, C, D, E, N, euglobal Ia1, 1a2, and eucalyptone were purchased from Biosynth (Staad, Switzerland). Sideroxylonal A was purchased through MedChemExpress (Monmouth Junction, NJ, USA).

4.3. Sample Extraction

Mushroom pieces from the first batch of samples (July 2024) were roughly divided into five groups and then split in half (n = 10 pieces of mushroom, ~1 g fresh weight) of approximately equal size. Half of the mushroom pieces were lyophilized (Labconco Freezone, MO, USA), and the other half of the pieces were extracted as raw segments. Various methods were tested to determine optimal extraction conditions for a comprehensive representation of secondary metabolites in the mushroom samples). Mushroom pieces were separately extracted (raw and lyophilized) in either (1) 79:20:1 acetonitrile: water: acetic acid (v/v/v), (2) hexane, (3) ethyl acetate, (4) methanol, or by (5) alkaloid extraction [104,105]. For extraction methods 1–4, raw and freeze-dried segments were added separately to 7 mL glass scintillation vials with 2 mL of specified solvent. The solutions were vortexed for 30 s and then sonicated at room temperature for 1 h. The supernatant from each vial was removed, added to clean 7 mL glass scintillation vials, and dried under nitrogen. Extracts were reconstituted in 1 mL acetonitrile, vortexed briefly, and filtered through 0.45 µm PTFE syringe filters (Fisher Scientific) into 2 mL amber HPLC vials (Agilent Technologies, Santa Clara, CA, USA) for analysis. The alkaloid extraction (5) was performed as per Di Mavungu et al. (2012), with some deviations [105]. Briefly, 10 mL portions of ethyl acetate phase were dried, and extracts were reconstituted in 400 µL of 20/40/40 methanol/acetonitrile/water.

4.4. LC–MS/MS Analysis

For LC–MS/MS screening of extraction methods 1–4, an Agilent 1290 Infinity HPLC was coupled to a Thermo Q-Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). For compound separation, 5 µL of each sample were injected onto an Zorbax Eclipse Plus RRHD column (2.1 × 50 mm, 1.8 µm; Agilent) held at 35 °C at a flow rate of 0.3 mL/min. Separation was achieved using mobile phases composed of Optima-grade H2O with 0.1% formic acid (A) and Optima-grade ACN with 0.1% formic acid (B). Mobile phase B was held at 0% for 30 s before ramping to 100% over 3 min. B was held at 100% for 2.5 min before ramping back to 0% over 30 s. Data dependent acquisition (DDA) was used in both positive and negative ionization modes for each sample using the HESI source. The following settings were used for DDA acquisition by full MS: scan range, 150–1600 m/z; resolution, 70,000; automatic gain control (AGC), 1 × 106; and max injection time (IT), 256 ms. The top 5 peaks from each full MS scan (by intensity) were selected for further analysis by MS/MS under a 1.2 m/z isolation window using the following settings: resolution, 17,500; AGC target, 1 × 105; max IT, 62 ms; NCE, 35; threshold intensity, 1.2 × 105; dynamic exclusion, 10 s. Analysis of eucalyptus standards was similarly investigated with different column chemistries to evaluate separation, including the Zorbax Eclipse Plus C8 RRHD (2.1 × 50 mm, 1.8 µm; Agilent) and an Accucore Phenyl-Hexyl (2.1 × 50 mm, 2.6 µm; Thermo Scientific). For the alkaloid extracts, chromatography conditions were adopted using Di Mavungu et al. (2012), using water/0.2 M ammonium bicarbonate pH 10/methanol (85/5/10 v/v/v, mobile phase A), and water/0.2 M ammonium bicarbonate pH 10/methanol (5/5/90 v/v/v, mobile phase B) [105]. All raw data files were analyzed using Thermo Xcalibur software using the Qual browser, Mzmine v. 4.1.0, and xcms and MetabolAnalyze packages in R v. 4.4.1 (r-project.org) using mzml converted files (Proteowizard) [106,107,108]. Peak lists were generated using R per Kelman et al. (2020) [109]. Compounds were identified using available analytical standards, previously compiled in-house databases, and comparison to published natural product spectral libraries in GNPS, Metabolomics of North America (MoNA), and MassBank. All detected abundant compounds were assigned a confidence ID (1–5) based on their comparison to analytical standards (1), spectral database matching (2), in-silico MS/MS, putative matches of known secondary metabolites or compound classes (3), or chemical formula (4).

Quantification and Semi-Quantification of Formylated Phloroglucinol Compounds

Due to the limited sample material available, only a single mushroom piece (n = 1, 235.3 mg fresh weight) could be used for quantification, so biological replicates could not be reported. Macrocarpals A, C, and N were quantified using commercial standards prepared neat in acetonitrile from 1 ng/mL to 10 µg/mL. Based on previous works, macrocarpal A was used as the surrogate compound in the semi-quantification of the total FPCs in the R. flavobrunnescens extract, as it was quantified in the highest amount [65,91]. Product ion filtering using the macrocarpal and sideroxylonal known product ions (m/z 207.0274, 249.0747 and 181.0119, [M-H]) was used to detect the molecular formulae of the total FPCs in the R. flavobrunnescens extract [65]. The peak areas of each molecular formulae were integrated in the full MS, and semi-quantified as macrocarpal A equivalents. The total FPC for the extract is reported as a sum of the integrated peak areas as macrocarpal A equivalents.

4.5. Surface Sterilization and Isolation of Microorganisms from Mushroom Segments

Small pieces of the mushroom (~1 cm × 0.5 cm) were surface-sterilized by briefly swirling in 95% ethanol for 1 min and then washing with sterile distilled water. Pieces were aseptically plated onto Malt Extract Agar (MEA) plates (Millipore Sigma, Burlington, MA, USA) and incubated at 25 °C until growth was observed. Individual fungal and bacterial colonies were streaked onto new MEA agar plates to select for single colony isolates. For each isolate, DNA was extracted (DNeasy UltraClean Microbial Kit, Qiagen, Toronto, ON, Canada) and amplified by PCR using either 16S bacterial 27F/1492R primers or ITS1/ITS4 primers (10 µM stocks, 1.5 µL each, Supplementary Table S1) in 25 µL reaction mixtures using 20 µL SuperMix (Thermo Platinum Blue PCR SuperMix) and 2 µL DNA. Amplified PCR products were cleaned with ExoSAP-IT (Thermo Fisher, manufacturer’s instructions), and sent to Eurofins (Louisville, KY, USA) for Sanger sequencing analysis (Eurofins SimpleSeq pre-paid tubes).

4.6. Growth and Extraction of Extrolites from Single Colony Isolates

Single colonies of bacteria from each isolate were inoculated into 7 mL Trypticase Soy Broth (TSB, BD BBL, Franklin Lakes, NJ, USA) in 15 mL conical tubes and capped with sterile foam plugs. Cultures were incubated in a shaking incubator maintained at 30 °C at 200 rpm for 48 h. Cultures were extracted using 7 mL of the mycotoxin mix (79:20:1 acetonitrile: water: acetic acid) in a 50 mL conical tube. Briefly, samples were sonicated at 30 °C for 30 min and then shaken on an orbital shaker at 250 rpm for 15 min. Conical tubes were centrifuged at 3220× g at 4 °C for 10 min. 500 µL of the supernatant was diluted with 500 µL of 50:50 acetonitrile: water, and syringe filtered using 0.45 µM PTFE filters into 2 mL amber HPLC vials. Samples were analyzed by LC–MS/MS as described above, but also with an inclusion list for the known WLIP/massetolide/viscosin compounds. Raw files were also converted into mzml file format (MS Convert) and analyzed using the GNPS library search. For fungal cultures, six agar plugs were excised from single colony isolates (MEA) using a 0.5 cm diameter cork borer into a 7 mL glass scintillation vial. Agar plugs were extracted with 2 mL ethyl acetate by sonication at 30 °C for 60 min in a sonicating water bath. The supernatant was removed and evaporated to dryness under a gentle stream of nitrogen, reconstituted in 1 mL acetonitrile, and syringe-filtered using 0.45 µM PTFE filters into 2 mL amber HPLC vials for LC–MS analysis.

4.7. Extraction of Fresh Eucalyptus Leaves and Essential Oil

The Eucalyptus ‘Glacier’ cultivar was purchased from a commercial greenhouse in Thorndale, Ontario. Briefly, 1.12 g of fresh weight eucalyptus leaves were harvested, manually torn, and ground using a mortar and pestle in 5 mL ethyl acetate. The organic extract was filtered through P1 filter paper with anhydrous sodium sulfate into a round-bottomed flask and evaporated to dryness on a rotary evaporator. The extract was reconstituted in approximately 2 mL ethyl acetate and evaporated to dryness using a centrivap vacuum concentrator (Labconco). For LC–MS analysis, the dried extract was reconstituted in 1 mL acetonitrile, diluted 100× in acetonitrile, and syringe-filtered by 0.45 µM PTFE into 2 mL amber HPLC vials.
Eucalyptus essential oil extract from Eucalyptus globulus was purchased locally. For the essential oil, 1 mL was extracted with 5 mL ethyl acetate. The organic portion was evaporated to dryness using a centrivap concentrator and reconstituted in 1 mL acetonitrile with sonication at 30 °C for 10 min. The extract was diluted 10× in acetonitrile, and syringe-filtered using 0.45 µM PTFE into 2 mL amber HPLC vials for LC–MS analysis.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxins18010053/s1. Table S1: Bacterial and fungal primers used for Sanger sequencing of isolated microorganisms from Ramaria flavobrunnescens; Table S2: Structurally related formylated phloroglucinol compounds (FPCs) detected by product ion filtering of m/z 207.0274 [M-H] from the Ramaria ethyl acetate extract. Compounds were then screened for their presence in eucalyptus leaf and essential oil extracts; Table S3: Retention time and high-resolution MS/MS fragmentation of commercially available eucalyptus standards; Table S4: Knowns and putative identifications; Table S5: Unknown compounds; Table S6: Peak tables showing differences between lyophilized and raw mushroom material; Figure S1: (A) Extracted ion chromatograms of the putatively identified ramariolides A–D in ethyl acetate extracts in negative ionization mode, highlighting relative abundances between them. (B) MS/MS of the putative ramariolides A/B, D, and C [M-H] from R. flavobrunnescens extracts; Figure S2: Product ion filtering in negative ionization mode of diagnostic fragment m/z 207.0274 for the Ramaria ethyl acetate extract, extracted eucalyptus leaves, and eucalyptus oil. The peaks and relative abundances detected highlight the diversity of the formylated phosphoglucinol compounds (FPCs) between the matrices; Figure S3: (A) Extracted ion chromatograms of 385.2029 [M-H] and (B) MS/MS for the Ramaria extract, euglobal Ia1, and euglobal Ia2; Figure S4: (A) Extracted ion chromatogram of 485.2568 [M-H] and (B) MS/MS fragmentation for the Ramaria extract, eucalyptone, and macrocarpal N; Figure S5: (A) Extracted ion chromatogram of 471.2772 [M-H] and (B) MS/MS fragmentation of the Ramaria ethyl acetate extract and macrocarpals A, D, and E; Figure S6: (A) Extracted ion chromatogram of 499.1609 [M-H] and (B) MS/MS fragmentation of the R. flavobrunnescens extract and sideroxylonal A; Figure S7: (A) Extracted ion chromatogram of 453.2646 [M-H] and (B) MS/MS fragmentation of the R. flavobrunnescens extract and macrocarpal C.

Author Contributions

Conceptualization, M.M. and M.W.S.; methodology, J.B.R. and M.J.K.; software, M.J.K.; validation, J.B.R. and M.W.S.; formal analysis, M.J.K.; investigation, M.J.K. and J.B.R.; resources, M.W.S. and M.M.; data curation, M.J.K.; writing—original draft preparation, M.J.K. and J.B.T.; writing—review and editing, M.J.K., M.W.S., J.B.R., J.B.T. and M.M.; visualization, M.J.K.; supervision, M.W.S., J.B.T. and M.M.; project administration, M.W.S. and J.B.R.; funding acquisition, M.W.S. and M.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

The data presented are available in the article and Supplementary Materials.

Acknowledgments

The authors gratefully acknowledge Natasha DesRochers, Cameron Littlejohn, James Singeris, and Sara Cordoba-Reyes (London Research and Development Centre/Western University) for technical assistance with sample extraction. We also wish to acknowledge J. David Miller and David McMullin (Carleton University, Ottawa, Ontario, Canada) for helpful guidance and manuscript comments. We thank Eleana Luque from the Plataforma de Investigación en Salud Animal (PSA) of the Instituto Nacional de Investigación Agropecuaria (INIA) for her assistance with sampling, and Hugo Longueira for the support. Mizael Machado is a researcher in the Sistema Nacional de Investigadores (SNI) of the Agencia Nacional de Investigación e Innovación (ANII), Uruguay.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
GNPSGlobal Natural Products Social Molecular Networking
HRMSHigh-resolution mass spectrometry
LC–MS/MSLiquid chromatography tandem mass spectrometry
TSBTrypticase soy broth
WLIPWhite line inducing principle
FPCFormylated phloroglucinol compound

References

  1. Hawksworth, D.L.; Lücking, R. Fungal diversity revisited: 2.2 to 3.8 million species. Microbiol. Spectr. 2017, 5, 1128. [Google Scholar] [CrossRef]
  2. He, M.-Q.; Wang, M.-Q.; Chen, Z.-H.; Deng, W.-Q.; Li, T.-H.; Vizzini, A.; Jeewon, R.; Hyde, K.D.; Zhao, R.-L. Potential benefits and harms: A review of poisonous mushrooms in the world. Fungal Biol. Rev. 2022, 42, 56–68. [Google Scholar] [CrossRef]
  3. Diaz, J.H. Amatoxin-containing mushroom poisonings: Species, toxidromes, treatments, and outcomes. Wilderness Environ. Med. 2018, 29, 111–118. [Google Scholar] [CrossRef] [PubMed]
  4. Lindahl, B.D.; Tunlid, A. Ectomycorrhizal fungi–potential organic matter decomposers, yet not saprotrophs. New Phytol. 2015, 205, 1443–1447. [Google Scholar] [CrossRef]
  5. Kluber, L.A.; Smith, J.E.; Myrold, D.D. Distinctive fungal and bacterial communities are associated with mats formed by ectomycorrhizal fungi. Soil Biol. Biochem. 2011, 43, 1042–1050. [Google Scholar] [CrossRef]
  6. Alves, D.M.; Marcolongo-Pereira, C.; Tavares, L.A.; Molarinho, K.R.; Raffi, M.B.; Schild, A.L.; Sallis, E.S.V. Criação de bovinos em sistema silvipastoril com eucalipto: Um risco para intoxicação por Ramaria flavo-brunnescens. Pesq. Vet. Bras. 2014, 34, 659–662. [Google Scholar] [CrossRef]
  7. Barros, R.R.; Irigoyen, L.F.; Kommers, G.D.; Rech, R.R.; Fighera, R.A.; Barros, C.S. Intoxicação por Ramaria flavo-brunnescens (Clavariaceae) em bovinos. Pesq. Vet. Bras. 2006, 26, 87–96. [Google Scholar] [CrossRef]
  8. Scheid, H.V.; Sallis, E.S.V.; Riet-Correa, F.; Schild, A.L. Ramaria flavo-brunnescens mushroom poisoning in South America: A comprehensive review. Toxicon 2022, 205, 91–98. [Google Scholar] [CrossRef]
  9. Fidalgo, O.; Fidalgo, M. A poisonous Ramaria from Southern Brazil. Rickia 1970, 5, 71–91. [Google Scholar]
  10. Sallis, E.S.; Raffi, M.B.; Riet-Correa, F. Intoxicação experimental em ovinos com Ramaria flavo-brunnescens congelada ou dessecada. Pesq. Vet. Bras. 2004, 24, 107–110. [Google Scholar] [CrossRef]
  11. Sallis, E.; Correa, F.; Raffi, M.; Méndez, M. Experimental intoxication by the mushroom Ramaria flavo-brunnescens in sheep. Vet. Hum. Toxicol. 2000, 42, 321–324. [Google Scholar]
  12. Kommers, G.; Santos, M. Experimental poisoning of cattle by the mushroom Ramaria flavo-brunnescens (Clavariaceae): A study of the morphology and pathogenesis of lesions in hooves, tail, horns and tongue. Vet. Hum. Toxicol. 1995, 37, 297–302. [Google Scholar]
  13. Trost, M.E.; Kommers, G.D.; Barros, C.S.; Schild, A.L. Patogênese das lesões associadas à intoxicação por Ramaria flavo-brunnescens em bovinos. Pesq. Vet. Bras. 2009, 29, 533–544. [Google Scholar] [CrossRef]
  14. Semwal, K.C.; Bhatt, V.K.; Hussen, A.; Chauhan, A. The Genus Ramaria (Basidiomycota, Agaricales): Diversity, Edibility, and Bioactivity. In Edible and Medicinal Mushrooms of the Himalayas; CRC Press: Boca Raton, FL, USA, 2023; pp. 247–266. [Google Scholar]
  15. Kumar Sharma, S.; Gautam, N. Chemical and bioactive profiling, and biological activities of coral fungi from northwestern Himalayas. Sci. Rep. 2017, 7, 46570. [Google Scholar] [CrossRef]
  16. Sharma, S.K.; Gautam, N.; Atri, N.S. Evaluation of mycelial nutrients, bioactive compounds, and antioxidants of five Himalayan entomopathogenic Ascomyceteous fungi from India. Int. J. Med. Mushrooms 2015, 17, 661–669. [Google Scholar] [CrossRef]
  17. Aprotosoaie, A.C.; Zavastin, D.E.; Mihai, C.-T.; Voichita, G.; Gherghel, D.; Silion, M.; Trifan, A.; Miron, A. Antioxidant and antigenotoxic potential of Ramaria largentii Marr & DE Stuntz, a wild edible mushroom collected from Northeast Romania. Food Chem. Toxicol. 2017, 108, 429–437. [Google Scholar] [CrossRef]
  18. Braeuer, S.; Borovička, J.; Glasnov, T.; de la Cruz, G.G.; Jensen, K.B.; Goessler, W. Homoarsenocholine–A novel arsenic compound detected for the first time in nature. Talanta 2018, 188, 107–110. [Google Scholar] [CrossRef] [PubMed]
  19. Kim, K.-C.; Lee, I.-S.; Yoo, I.-D.; Ha, B.-J. Sesquiterpenes from the fruiting bodies of Ramaria formosa and their human neutrophil elastase inhibitory activity. Chem. Pharm. Bull. 2015, 63, 554–557. [Google Scholar] [CrossRef] [PubMed]
  20. Centko, R.M.; Ramon-Garcia, S.; Taylor, T.; Patrick, B.O.; Thompson, C.J.; Miao, V.P.; Andersen, R.J. Ramariolides A–D, antimycobacterial butenolides isolated from the mushroom Ramaria cystidiophora. J. Nat. Prod. 2012, 75, 2178–2182. [Google Scholar] [CrossRef]
  21. Kanokmedhakul, S.; Lekphrom, R.; Kanokmedhakul, K.; Hahnvajanawong, C.; Bua-Art, S.; Saksirirat, W.; Prabpai, S.; Kongsaeree, P. Cytotoxic sesquiterpenes from luminescent mushroom Neonothopanus nambi. Tetrahedron 2012, 68, 8261–8266. [Google Scholar] [CrossRef]
  22. Itokawa, H.; Masuyama, K.; Morita, H.; Takeya, K. Cytotoxic sesquiterpenes from Nardostachys chinensis. Chem. Pharm. Bull. 1993, 41, 1183–1184. [Google Scholar] [CrossRef]
  23. Rodríguez, B.; de la Torre, M.C.; Simoes, F.; Batista, O.; Nascimento, J.; Duarte, A.; Mayer, R. Revision of the structure of an aristolane sesquiterpene aldehyde isolated from the root of Plectranthus hereroensis and Aristolochia debilis. Phytochemistry 1995, 38, 905–907. [Google Scholar] [CrossRef]
  24. Choodej, S.; Pudhom, K.; Yamauchi, K.; Mitsunaga, T. Inhibition of melanin production by sesquiterpene lactones from Saussurea lappa and their analogues. Med. Chem. Res. 2019, 28, 857–862. [Google Scholar] [CrossRef]
  25. Serpe, F.P.; Russo, R.; Gallo, P.; Severino, L. Method for Speciation of Organoarsenic in Mussels by Liquid Chromatography Coupled to Electrospray Ionization and QTRAP Tandem Mass Spectrometry. J. Food Prot. 2013, 76, 1293–1299. [Google Scholar] [CrossRef]
  26. Wang, M.; Rogers, S.; Bittremieux, W.; Chen, C.; Dorrestein, P.C.; Schymanski, E.L.; Schulze, T.; Neumann, S.; Meier, R. Interactive MS/MS Visualization with the Metabolomics Spectrum Resolver Web Service. bioRxiv 2020. [Google Scholar] [CrossRef]
  27. Walenta, M.; Raab, A.; Braeuer, S.; Steiner, L.; Borovička, J.; Goessler, W. Arsenobetaine amide: A novel arsenic species detected in several mushroom species. Anal. Bioanal. Chem. 2024, 416, 1399–1405. [Google Scholar] [CrossRef]
  28. Šlejkovec, Z.; Byrne, A.R.; Stijve, T.; Goessler, W.; Irgolic, K. Arsenic compounds in higher fungi. Appl. Organomet. Chem. 1997, 11, 673–682. [Google Scholar] [CrossRef]
  29. Nearing, M.M.; Koch, I.; Reimer, K.J. Arsenic speciation in edible mushrooms. Environ. Sci. Technol. 2014, 48, 14203–14210. [Google Scholar] [CrossRef] [PubMed]
  30. Hughes, M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 2002, 133, 1–16. [Google Scholar] [CrossRef] [PubMed]
  31. Shen, S.; Li, X.-F.; Cullen, W.R.; Weinfeld, M.; Le, X.C. Arsenic binding to proteins. Chem. Rev. 2013, 113, 7769–7792. [Google Scholar] [CrossRef]
  32. Braeuer, S.; Borovička, J.; Kameník, J.; Prall, E.; Stijve, T.; Goessler, W. Is arsenic responsible for the toxicity of the hyperaccumulating mushroom Sarcosphaera coronaria? Sci. Total Environ. 2020, 736, 139524. [Google Scholar] [CrossRef]
  33. Ghosh, P.; Rathinasabapathi, B.; Teplitski, M.; Ma, L.Q. Bacterial ability in AsIII oxidation and AsV reduction: Relation to arsenic tolerance, P uptake, and siderophore production. Chemosphere 2015, 138, 995–1000. [Google Scholar] [CrossRef]
  34. Liu, X.; Fu, J.W.; Da Silva, E.; Shi, X.X.; Cao, Y.; Rathinasabapathi, B.; Chen, Y.; Ma, L.Q. Microbial siderophores and root exudates enhanced goethite dissolution and Fe/As uptake by As-hyperaccumulator Pteris vittata. Environ. Pollut. 2017, 223, 230–237. [Google Scholar] [CrossRef] [PubMed]
  35. Koch, I.; Dee, J.; House, K.; Sui, J.; Zhang, J.; McKnight-Whitford, A.; Reimer, K.J. Bioaccessibility and speciation of arsenic in country foods from contaminated sites in Canada. Sci. Total Environ. 2013, 449, 1–8. [Google Scholar] [CrossRef] [PubMed]
  36. Zhou, L.; Wang, S.; Hao, Q.; Kang, L.; Kang, C.; Yang, J.; Yang, W.; Jiang, J.; Huang, L.-Q.; Guo, L. Bioaccessibility and risk assessment of heavy metals, and analysis of arsenic speciation in Cordyceps sinensis. Chin. Med. 2018, 13, 40. [Google Scholar] [CrossRef]
  37. Komorowicz, I.; Hanć, A.; Lorenc, W.; Barałkiewicz, D.; Falandysz, J.; Wang, Y. Arsenic speciation in mushrooms using dimensional chromatography coupled to ICP-MS detector. Chemosphere 2019, 233, 223–233. [Google Scholar] [CrossRef] [PubMed]
  38. Sakemi, Y.; Nakanishi, H.; Araki, Y.; Shindo, K. Antioxidant activities of pistillarin in the clustered coral mushroom, Ramaria botrytis (Agaricomycetes), and discovery of pistillarin B. Int. J. Med. Mushrooms 2022, 24, 67–75. [Google Scholar] [CrossRef]
  39. Cheung, L.; Cheung, P.C. Mushroom extracts with antioxidant activity against lipid peroxidation. Food Chem. 2005, 89, 403–409. [Google Scholar] [CrossRef]
  40. Capon, R.J.; Stewart, M.; Ratnayake, R.; Lacey, E.; Gill, J.H. Citromycetins and bilains A–C: New aromatic polyketides and diketopiperazines from Australian marine-derived and terrestrial Penicillium spp. J. Nat. Prod. 2007, 70, 1746–1752. [Google Scholar] [CrossRef]
  41. Lo Cantore, P.; Lazzaroni, S.; Evidente, A.; Cafarchia, C.; Iacobellis, N.S. Production of Tolaasin I and WLIP by Pseudomonas tolaasii and P. “reactans”, their Antimicrobial Activity and Possible Role in the Virulence of the Pathogens. In Pseudomonas syringae and Related Pathogens: Biology and Genetic; Springer: Dordrecht, The Netherlands, 2003; pp. 255–262. [Google Scholar]
  42. Rokni-Zadeh, H.; Li, W.; Sanchez-Rodriguez, A.; Sinnaeve, D.; Rozenski, J.; Martins, J.C.; De Mot, R. Genetic and functional characterization of cyclic lipopeptide white-line-inducing principle (WLIP) production by rice rhizosphere isolate Pseudomonas putida RW10S2. Appl. Environ. Microbiol. 2012, 78, 4826–4834. [Google Scholar] [CrossRef]
  43. De Bruijn, I.; de Kock, M.J.; de Waard, P.; van Beek, T.A.; Raaijmakers, J.M. Massetolide A biosynthesis in Pseudomonas fluorescens. J. Bacteriol. 2008, 190, 2777–2789. [Google Scholar] [CrossRef]
  44. Coraiola, M.; Cantore, P.L.; Lazzaroni, S.; Evidente, A.; Iacobellis, N.S.; Dalla Serra, M. WLIP and tolaasin I, lipodepsipeptides from Pseudomonas reactans and Pseudomonas tolaasii, permeabilise model membranes. Biochim. Biophys. Acta. Biomembr. 2006, 1758, 1713–1722. [Google Scholar] [CrossRef]
  45. Guan, Y.; Bak, F.; Hennessy, R.C.; Horn Herms, C.; Elberg, C.L.; Dresbøll, D.B.; Winding, A.; Sapkota, R.; Nicolaisen, M.H. The potential of Pseudomonas fluorescens SBW25 to produce viscosin enhances wheat root colonization and shapes root-associated microbial communities in a plant genotype-dependent manner in soil systems. Msphere 2024, 9, e00294-24. [Google Scholar] [CrossRef]
  46. Alsohim, A.S.; Taylor, T.B.; Barrett, G.A.; Gallie, J.; Zhang, X.X.; Altamirano-Junqueira, A.E.; Johnson, L.J.; Rainey, P.B.; Jackson, R.W. The biosurfactant viscosin produced by P seudomonas fluorescens SBW 25 aids spreading motility and plant growth promotion. Environ. Microbiol. 2014, 16, 2267–2281. [Google Scholar] [CrossRef] [PubMed]
  47. Johnson, G.V.; Lopez, A.; La Valle Foster, N. Reduction and transport of Fe from siderophores. Plant Soil 2002, 241, 27–33. [Google Scholar] [CrossRef]
  48. Op De Beeck, M.; Troein, C.; Peterson, C.; Persson, P.; Tunlid, A. Fenton reaction facilitates organic nitrogen acquisition by an ectomycorrhizal fungus. New Phytol. 2018, 218, 335–343. [Google Scholar] [CrossRef] [PubMed]
  49. Chen, S.; Zhu, M.; Guo, X.; Yang, B.; Zhuo, R. Coupling of Fenton reaction and white rot fungi for the degradation of organic pollutants. Ecotoxicol. Environ. Saf. 2023, 254, 114697. [Google Scholar] [CrossRef]
  50. Grimont, P.; Farmer, J., III; Grimont, F.; Asbury, M.; Brenner, D.; Deval, C. Ewingella americana gen. nov., sp. nov., a new Enterobacteriaceae isolated from clinical specimens. In Annales De l’Institut Pasteur/Microbiologie; Elsevier: Amsterdam, The Netherlands, 1983; pp. 39–52. [Google Scholar]
  51. Hamidizade, M.; Taghavi, S.M.; Moallem, M.; Aeini, M.; Fazliarab, A.; Abachi, H.; Herschlag, R.A.; Hockett, K.L.; Bull, C.T.; Osdaghi, E. Ewingella americana: An emerging multifaceted pathogen of edible mushrooms. Phytopathology 2023, 113, 150–159. [Google Scholar] [CrossRef]
  52. Reyes, J.E.; Venturini, M.E.; Oria, R.; Blanco, D. Prevalence of Ewingella americana in retail fresh cultivated mushrooms (Agaricus bisporus, Lentinula edodes and Pleurotus ostreatus) in Zaragoza (Spain). FEMS Microbiol. Ecol. 2004, 47, 291–296. [Google Scholar] [CrossRef]
  53. Liu, Z.; Sossah, F.; Li, Y.; Fu, Y. First report of Ewingella americana causing bacterial brown rot disease on cultivated needle mushroom (Flammulina velutipes) in China. Plant Dis. 2018, 102, 2633. [Google Scholar] [CrossRef]
  54. Starke, R.; Morais, D.; Větrovský, T.; López Mondéjar, R.; Baldrian, P.; Brabcová, V. Feeding on fungi: Genomic and proteomic analysis of the enzymatic machinery of bacteria decomposing fungal biomass. Environ. Microbiol. 2020, 22, 4604–4619. [Google Scholar] [CrossRef]
  55. Babalola, O.; Akindolire, A. Identification of native rhizobacteria peculiar to selected food crops in Mmabatho municipality of South Africa. Biol. Agric. Hortic. 2011, 27, 294–309. [Google Scholar] [CrossRef]
  56. Müller, H.E.; Fanning, G.R.; Brenner, D.J. Isolation of Ewingella americana from mollusks. Curr. Microbiol. 1995, 31, 287–290. [Google Scholar] [CrossRef]
  57. Lyon, W.; Milliet, J. Microbial flora associated with Louisiana processed frozen and fresh nutria (Myocastor coypus) carcasses. J. Food Sci. 2000, 65, 1041–1045. [Google Scholar] [CrossRef]
  58. Helps, C.R.; Harbour, D.A.; Corry, J.E. PCR-based 16S ribosomal DNA detection technique for Clostridium estertheticum causing spoilage in vacuum-packed chill-stored beef. Int. J. Food Microbiol. 1999, 52, 57–65. [Google Scholar] [CrossRef]
  59. Ioannou, P.; Baliou, S.; Kofteridis, D. Ewingella americana Infections in Humans—A Narrative Review. Antibiotics 2024, 13, 559. [Google Scholar] [CrossRef]
  60. Stock, I.; Sherwood, K.; Wiedemann, B. Natural antibiotic susceptibility of Ewingella americana strains. J. Chemother. 2003, 15, 428–441. [Google Scholar] [CrossRef]
  61. Khleifat, K.M. Biodegradation of phenol by Ewingella americana: Effect of carbon starvation and some growth conditions. Process Biochem. 2006, 41, 2010–2016. [Google Scholar] [CrossRef]
  62. Mortishire-Smith, R.; Nutkins, J.; Packman, L.; Brodey, C.; Rainey, P.; Johnstone, K.; Williams, D. Determination of the structure of an extracellular peptide produced by the mushroom saprotroph Pseudomonas reactans. Tetrahedron 1991, 47, 3645–3654. [Google Scholar] [CrossRef]
  63. Berendsen, R.L.; Kalkhove, S.I.; Lugones, L.G.; Baars, J.J.; Wösten, H.A.; Bakker, P.A. Effects of fluorescent Pseudomonas spp. isolated from mushroom cultures on Lecanicillium fungicola. Biol. Control 2012, 63, 210–221. [Google Scholar] [CrossRef]
  64. Lo Cantore, P.; Lazzaroni, S.; Coraiola, M.; Serra, M.D.; Cafarchia, C.; Evidente, A.; Iacobellis, N.S. Biological characterization of white line-inducing principle (WLIP) produced by Pseudomonas reactans NCPPB1311. Mol. Plant. Microbe Interact. 2006, 19, 1113–1120. [Google Scholar] [CrossRef]
  65. Santos, B.M.d.; Zibrandtsen, J.F.; Gunbilig, D.; Sørensen, M.; Cozzi, F.; Boughton, B.A.; Heskes, A.M.; Neilson, E.H.J. Quantification and localization of formylated phloroglucinol compounds (FPCs) in Eucalyptus species. Front. Plant Sci. 2019, 10, 186. [Google Scholar] [CrossRef] [PubMed]
  66. Eschler, B.M.; Pass, D.M.; Willis, R.; Foley, W.J. Distribution of foliar formylated phloroglucinol derivatives amongst Eucalyptus species. Biochem. Syst. Ecol. 2000, 28, 813–824. [Google Scholar] [CrossRef]
  67. Murata, M.; Yamakoshi, Y.; Homma, S.; Aida, K.; Hori, K.; Ohashi, Y. Macrocarpal A, a novel antibacterial compound from Eucalyptus macrocarpa. Agric. Biol. Chem. 1990, 54, 3221–3226. [Google Scholar] [CrossRef]
  68. Okba, M.M.; El Gedaily, R.A.; Ashour, R.M. UPLC–PDA–ESI–qTOF-MS profiling and potent anti-HSV-II activity of Eucalyptus sideroxylon leaves. J. Chromatogr. B 2017, 1068–1069, 335–342. [Google Scholar] [CrossRef]
  69. Osawa, K.; Yasuda, H.; Morita, H.; Takeya, K.; Itokawa, H. Eucalyptone from Eucalyptus globulus. Phytochemistry 1995, 40, 183–184. [Google Scholar] [CrossRef]
  70. Brezáni, V.; Šmejkal, K. Secondary metabolites isolated from the genus Eucalyptus. Curr. Trend Med. Chem. 2013, 7, 65–95. [Google Scholar]
  71. Osawa, K.; Yasuda, H.; Morita, H.; Takeya, K.; Itokawa, H. Configuraitonal and conformational analysis of Macrocarpals H, I, and J from Eucalyptus globulus. Chem. Pharm. Bull. 1997, 45, 1216–1217. [Google Scholar] [CrossRef][Green Version]
  72. Pal Singh, I.; Etoh, H. New macrocarpal-am-1 from Eucalyptus amplifolia. Biosci. Biotechnol. Biochem. 1995, 59, 2330–2332. [Google Scholar] [CrossRef]
  73. Zhang, Q.; Ma, Q.; Wang, Y.; Wu, H.; Zou, J. Molecular mechanisms of inhibiting glucosyltransferases for biofilm formation in Streptococcus mutans. Int. J. Oral Sci. 2021, 13, 30. [Google Scholar] [CrossRef]
  74. Typas, A.; Banzhaf, M.; Gross, C.A.; Vollmer, W. From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat. Rev. Microbiol. 2012, 10, 123–136. [Google Scholar] [CrossRef]
  75. Wiggins, N.L.; Marsh, K.J.; Wallis, I.R.; Foley, W.J.; McArthur, C. Sideroxylonal in Eucalyptus foliage influences foraging behaviour of an arboreal folivore. Oecologia 2006, 147, 272–279. [Google Scholar] [CrossRef]
  76. Mieres-Castro, D.; Ahmar, S.; Shabbir, R.; Mora-Poblete, F. Antiviral activities of eucalyptus essential oils: Their effectiveness as therapeutic targets against human viruses. Pharmaceuticals 2021, 14, 1210. [Google Scholar] [CrossRef]
  77. Ivanov, M.; Kannan, A.; Stojković, D.S.; Glamočlija, J.; Calhelha, R.C.; Ferreira, I.C.; Sanglard, D.; Soković, M. Camphor and eucalyptol—Anticandidal spectrum, antivirulence effect, efflux pumps interference and cytotoxicity. Int. J. Mol. Sci. 2021, 22, 483. [Google Scholar] [CrossRef]
  78. Mulyaningsih, S.; Sporer, F.; Reichling, J.; Wink, M. Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens. Pharm. Biol. 2011, 49, 893–899. [Google Scholar] [CrossRef] [PubMed]
  79. Edwards, P.B.; Wanjura, W.; Brown, W. Selective herbivory by Christmas beetles in response to intraspecific variation in Eucalyptus terpenoids. Oecologia 1993, 95, 551–557. [Google Scholar] [CrossRef] [PubMed]
  80. Corbet, S.A.; Danahar, G.; King, V.; Chalmers, C.; Tiley, C. Surfactant-enhanced essential oils as mosquito larvicides. Entomol. Exp. Appl. 1995, 75, 229–236. [Google Scholar] [CrossRef]
  81. Stone, C.; Bacon, P.E. Relationships among moisture stress, insect herbivory, foliar cineole content and the growth of river red gum Eucalyptus camaldulensis. J. Appl. Ecol. 1994, 31, 604–612. [Google Scholar] [CrossRef]
  82. Ittyachen, A.M.; George, G.R.; Radhakrishnan, M.; Joy, Y. Eucalyptus oil poisoning: Two case reports. J. Med. Case Rep. 2019, 13, 326. [Google Scholar] [CrossRef] [PubMed]
  83. Sitaraman, R.; Rao, G. A Pediatric Case of Accidental Eucalyptus Oil Poisoning from New Delhi, India: Emergency Measures, Historical Context, and Implications for Practice. Cureus 2019, 11, e5734. [Google Scholar] [CrossRef]
  84. Suresh, D.; VijayaKumar, S.; Pradhan, P.; Balasubramanian, S. Fatal Eucalyptus Oil Poisoning in an Adult Male: A Case Report with Comprehensive Autopsy and Histopathological Findings. Cureus 2025, 17, e83053. [Google Scholar] [CrossRef]
  85. Kumar, K.J.; Sonnathi, S.; Anitha, C.; Santhoshkumar, M. Eucalyptus oil poisoning. Toxicol. Int. 2015, 22, 170. [Google Scholar] [CrossRef] [PubMed]
  86. Dreisinger, N.; Zane, D.; Etwaru, K. A poisoning of topical importance. Pediatr. Emerg. Care 2006, 22, 827–829. [Google Scholar] [CrossRef]
  87. Ernst, E. Serious adverse effects of unconventional therapies for children and adolescents: A systematic review of recent evidence. Eur. J. Pediatr. 2003, 162, 72–80. [Google Scholar] [CrossRef]
  88. Mozafari, N.; Talaie, H.; Shoaei, S.D.; Hashemian, M.; Mahdavinejad, A. Survey on hypothermia and hyperthermia in poisoned patients in a unique referral hospital, Tehran, Iran. Iran. Red Crescent Med. J. 2016, 18, e35483. [Google Scholar] [CrossRef] [PubMed]
  89. Gharib, R.; Jemâa, J.M.B.; Charcosset, C.; Fourmentin, S.; Greige-Gerges, H. Retention of Eucalyptol, a Natural Volatile Insecticide, in Delivery Systems Based on Hydroxypropyl-β-Cyclodextrin and Liposomes. Eur. J. Lipid Sci. Technol. 2020, 122, 1900402. [Google Scholar] [CrossRef]
  90. Okba, M.M.; El-Shiekh, R.A.; Abu-Elghait, M.; Sobeh, M.; Ashour, R.M. HPLC-PDA-ESI-MS/MS profiling and anti-biofilm potential of Eucalyptussideroxylon flowers. Antibiotics 2021, 10, 761. [Google Scholar] [CrossRef] [PubMed]
  91. Machado, M.; Martínez, R.; Andres, S.; Sumarah, M.W.; Renaud, J.B.; Armién, A.G.; Barros, C.S.L.; Riet-Correa, F.; Menchaca, A.; Schild, C.O. Poisoning by Baccharis coridifolia in Early-Weaned Beef Calves: Pathological Study and New Macrocyclic Trichothecene Identification. Toxins 2023, 15, 681. [Google Scholar] [CrossRef]
  92. Omarini, A.; Dambolena, J.S.; Lucini, E.; Jaramillo Mejía, S.; Albertó, E.; Zygadlo, J.A. Biotransformation of 1, 8-cineole by solid-state fermentation of Eucalyptus waste from the essential oil industry using Pleurotus ostreatus and Favolus tenuiculus. Folia Microbiol. 2016, 61, 149–157. [Google Scholar] [CrossRef]
  93. Külheim, C.; Padovan, A.; Hefer, C.; Krause, S.T.; Köllner, T.G.; Myburg, A.A.; Degenhardt, J.; Foley, W.J. The Eucalyptus terpene synthase gene family. BMC Genom. 2015, 16, 450. [Google Scholar] [CrossRef]
  94. Adamczyk, S.; Adamczyk, B.; Kitunen, V.; Smolander, A. Monoterpenes and higher terpenes may inhibit enzyme activities in boreal forest soil. Soil Biol. Biochem. 2015, 87, 59–66. [Google Scholar] [CrossRef]
  95. George, H.L.; VanEtten, H.D. Characterization of pisatin-inducible cytochrome P450s in fungal pathogens of pea that detoxify the pea phytoalexin pisatin. Fungal Genet. Biol. 2001, 33, 37–48. [Google Scholar] [CrossRef]
  96. Chen, J.; Ullah, C.; Reichelt, M.; Beran, F.; Yang, Z.-L.; Gershenzon, J.; Hammerbacher, A.; Vassão, D.G. The phytopathogenic fungus Sclerotinia sclerotiorum detoxifies plant glucosinolate hydrolysis products via an isothiocyanate hydrolase. Nat. Commun. 2020, 11, 3090. [Google Scholar] [CrossRef]
  97. Cao, L.; Yu, S.; Zhang, L.; Zhang, X.; Li, Y. Biotransformation of ginsenosides by glycoside hydrolase from an endophytic fungus of Panax ginseng. Biotechnol. Biotechnol. Equip. 2024, 38, 2362852. [Google Scholar] [CrossRef]
  98. Kusari, S.; Zühlke, S.; Spiteller, M. An endophytic fungus from Camptotheca acuminata that produces camptothecin and analogues. J. Nat. Prod. 2009, 72, 2–7. [Google Scholar] [CrossRef]
  99. Natarajan, S.; Pucker, B.; Srivastava, S. Genomic and transcriptomic analysis of camptothecin producing novel fungal endophyte: Alternaria burnsii NCIM 1409. Sci. Rep. 2023, 13, 14614. [Google Scholar] [CrossRef]
  100. Eyberger, A.L.; Dondapati, R.; Porter, J.R. Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin. J. Nat. Prod. 2006, 69, 1121–1124. [Google Scholar] [CrossRef] [PubMed]
  101. Kusari, S.; Košuth, J.; Čellárová, E.; Spiteller, M. Survival-strategies of endophytic Fusarium solani against indigenous camptothecin biosynthesis. Fungal Ecol. 2011, 4, 219–223. [Google Scholar] [CrossRef]
  102. Safronov, O.; Bal, G.L.; Sipari, N.; Wilkens, M.; Safdari, P.; Smolander, O.-P.; Laine, P.K.; Lihavainen, J.; Silvan, N.; Rajaraman, S. Independent evolution of betulin biosynthesis in Inonotus obliquus. Sci. Rep. 2025, 15, 21319. [Google Scholar] [CrossRef] [PubMed]
  103. Isaka, M.; Palasarn, S.; Sakayaroj, J.; Srichomthong, K.; Nithithanasilp, S.; Sappan, M. Limonoids from fruiting bodies of the wood-rot basidiomycete Fulvifomes xylocarpicola associated with the mangrove tree Xylocarpus granatum. Phytochemistry 2021, 181, 112555. [Google Scholar] [CrossRef]
  104. Sulyok, M.; Krska, R.; Schuhmacher, R. A liquid chromatography/tandem mass spectrometric multi-mycotoxin method for the quantification of 87 analytes and its application to semi-quantitative screening of moldy food samples. Anal. Bioanal. Chem. 2007, 389, 1505–1523. [Google Scholar] [CrossRef]
  105. Di Mavungu, J.D.; Malysheva, S.V.; Sanders, M.; Larionova, D.; Robbens, J.; Dubruel, P.; Van Peteghem, C.; De Saeger, S. Development and validation of a new LC–MS/MS method for the simultaneous determination of six major ergot alkaloids and their corresponding epimers. Application to some food and feed commodities. Food Chem. 2012, 135, 292–303. [Google Scholar] [CrossRef]
  106. Schmid, R.; Heuckeroth, S.; Korf, A.; Smirnov, A.; Myers, O.; Dyrlund, T.S.; Bushuiev, R.; Murray, K.J.; Hoffmann, N.; Lu, M. Integrative analysis of multimodal mass spectrometry data in MZmine 3. Nat. Biotechnol. 2023, 41, 447–449. [Google Scholar] [CrossRef] [PubMed]
  107. Gift, N.; Brennan, L.; Gormley, I. Probabilistic principal components analysis for metabolomic data. BMC Bioinform. 2010, 11, 571. [Google Scholar] [CrossRef] [PubMed]
  108. Smith, C.A.; Want, E.J.; O’Maille, G.; Abagyan, R.; Siuzdak, G. XCMS:  Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and Identification. Anal. Chem. 2006, 78, 779–787. [Google Scholar] [CrossRef]
  109. Kelman, M.J.; Renaud, J.B.; Seifert, K.A.; Mack, J.; Yeung, K.K.-C.; Sumarah, M.W. Chemotaxonomic profiling of Canadian Alternaria populations using high-resolution mass spectrometry. Metabolites 2020, 10, 238. [Google Scholar] [CrossRef]
Figure 1. Ramaria flavobrunnescens fruiting body growing near a silvopastoral system in Uruguay.
Figure 1. Ramaria flavobrunnescens fruiting body growing near a silvopastoral system in Uruguay.
Toxins 18 00053 g001
Figure 2. Known Ramaria secondary metabolites detected in mushroom extracts.
Figure 2. Known Ramaria secondary metabolites detected in mushroom extracts.
Toxins 18 00053 g002
Figure 3. Arsenic-containing compounds detected in Ramaria flavobrunnescens.
Figure 3. Arsenic-containing compounds detected in Ramaria flavobrunnescens.
Toxins 18 00053 g003
Figure 4. The structure of the iron-chelating siderophore pistillarin.
Figure 4. The structure of the iron-chelating siderophore pistillarin.
Toxins 18 00053 g004
Figure 5. Structures of cyclic nonapeptides putatively detected in R. flavobrunnescens extracts with β-decanoyl group, and diversity of stereochemistry between structures. Circled areas highlight the amino acid stereochemistry differences between the compounds.
Figure 5. Structures of cyclic nonapeptides putatively detected in R. flavobrunnescens extracts with β-decanoyl group, and diversity of stereochemistry between structures. Circled areas highlight the amino acid stereochemistry differences between the compounds.
Toxins 18 00053 g005
Figure 6. (A) Extracted ion chromatograms highlighting major eucalyptus compounds detected in R. flavobrunnescens extracts compared to extracts of eucalyptus essential oil and fresh eucalyptus leaves. (B) Associated MS/MS fragmentation of m/z 471.2757 and 485.2527 [M-H] at most intense MS/MS peaks in the mushroom, essential oil, and eucalyptus leaf extracts.
Figure 6. (A) Extracted ion chromatograms highlighting major eucalyptus compounds detected in R. flavobrunnescens extracts compared to extracts of eucalyptus essential oil and fresh eucalyptus leaves. (B) Associated MS/MS fragmentation of m/z 471.2757 and 485.2527 [M-H] at most intense MS/MS peaks in the mushroom, essential oil, and eucalyptus leaf extracts.
Toxins 18 00053 g006
Figure 7. Putative formylated phloroglucinol compounds (FPCs) in ethyl acetate mushroom extracts with commercial standards available. Euglobal Ia1, macrocarpal D, and macrocarpal E were not detected in ethyl acetate extracts.
Figure 7. Putative formylated phloroglucinol compounds (FPCs) in ethyl acetate mushroom extracts with commercial standards available. Euglobal Ia1, macrocarpal D, and macrocarpal E were not detected in ethyl acetate extracts.
Toxins 18 00053 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kelman, M.J.; Renaud, J.B.; Tanney, J.B.; Machado, M.; Sumarah, M.W. High-Resolution LC–MS Characterization of Ramaria flavobrunnescens, a Coral Mushroom Toxic to Livestock, Reveals Fungal, Bacterial, and Eucalyptus Tree Metabolites. Toxins 2026, 18, 53. https://doi.org/10.3390/toxins18010053

AMA Style

Kelman MJ, Renaud JB, Tanney JB, Machado M, Sumarah MW. High-Resolution LC–MS Characterization of Ramaria flavobrunnescens, a Coral Mushroom Toxic to Livestock, Reveals Fungal, Bacterial, and Eucalyptus Tree Metabolites. Toxins. 2026; 18(1):53. https://doi.org/10.3390/toxins18010053

Chicago/Turabian Style

Kelman, Megan J., Justin B. Renaud, Joey B. Tanney, Mizael Machado, and Mark W. Sumarah. 2026. "High-Resolution LC–MS Characterization of Ramaria flavobrunnescens, a Coral Mushroom Toxic to Livestock, Reveals Fungal, Bacterial, and Eucalyptus Tree Metabolites" Toxins 18, no. 1: 53. https://doi.org/10.3390/toxins18010053

APA Style

Kelman, M. J., Renaud, J. B., Tanney, J. B., Machado, M., & Sumarah, M. W. (2026). High-Resolution LC–MS Characterization of Ramaria flavobrunnescens, a Coral Mushroom Toxic to Livestock, Reveals Fungal, Bacterial, and Eucalyptus Tree Metabolites. Toxins, 18(1), 53. https://doi.org/10.3390/toxins18010053

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop